The European Commission has restricted Chinese companies from certain EU public tenders for medical devices, in a response to unfair market access for EU firms in China.
On Friday, the European Commission introduced a measure after an investigation under the International Procurement Instrument, effective since August 2022, marking its first use to ensure fair access for EU companies to global procurement markets, it announced in a June 19 statement.